ARTICLE
|
doi:10.20944/preprints202212.0542.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
safety analysis; targeted therapy; monoclonal antibody therapy; immune checkpoint inhibibitors; tyrosine kinase inhibitors; breast cancer; gynecological cancer; Helixor; Viscum album L.; PARP inhibitors; CDK 4/6 inhibitors
Online: 30 December 2022 (12:00:35 CET)
REVIEW
|
doi:10.20944/preprints202207.0141.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
review; real -world evidence; real -world data; randomized controlled trials; registry; digital health technology; early drug approval
Online: 8 July 2022 (11:09:58 CEST)
ARTICLE
|
doi:10.20944/preprints202203.0029.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
blood component removal; C-reactive protein; CRP apheresis; COVID-19; multiple organ fail-ure; pulmonary fibrosis; SARS virus
Online: 2 March 2022 (02:34:23 CET)